Exhibit 107
Calculation of Filing Fee Table
Form S-8
(Form Type)
BioAge Labs, Inc.
(Exact Name of Registrant as Specified in its Charter)
Newly Registered Securities
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|
|||||||
Security Type |
|
Security Class Title |
|
Fee Calculation Rule |
|
Amount |
|
Proposed |
|
Maximum Price |
|
Fee Rate |
|
Amount of Fee |
|
|
|
|
|
|
|
|
|||||||
Equity |
|
Common Stock, per share |
|
Rule 457(c) and Rule 457(h) |
|
1,792,501(2) |
|
$4.29(3) |
|
$7,689,830.00 |
|
$0.0001531 |
|
$1,178.00 |
|
|
|
|
|
|
|
|
|||||||
Equity |
|
Common Stock, per share |
|
Rule 457(c) and Rule 457(h) |
|
358,500(4) |
|
$3.64(5) |
|
$1,304,940.00 |
|
$0.0001531 |
|
$200.00 |
|
|
|
|
|
|
|
|
|||||||
|
|
|
|
|
||||||||||
Total Offering Amounts |
|
|
|
$8,994,770.00 |
|
$N/A |
|
$1,378.00 |
||||||
|
|
|
|
|
||||||||||
Total Fee Offsets(6) |
|
|
|
|
|
|
|
— |
||||||
|
|
|
|
|
||||||||||
Net Fee Due |
|
|
|
|
|
|
|
$1,378.00 |
(1) |
Pursuant to Rule 416(a) under the Securities Act of 1933, as amended (the “Securities Act”), this Registration Statement shall also cover any additional shares of the Registrant’s common stock, par value $0.00001 per share (“common stock”), that becomes issuable pursuant to the provisions of the Registrant’s 2024 Equity Incentive Plan (“2024 EIP”) and 2024 Employee Stock Purchase Plan (“2024 ESPP”) by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without the Registrant’s receipt of consideration which results in an increase in the number of the Registrant’s outstanding shares of common stock. |
(2) |
Represents additional shares of common stock to be registered and available for grant under the 2024 EIP resulting from the annual 5% automatic increase in the number of authorized shares available for issuance under the 2024 EIP. |
(3) |
Estimated in accordance with Rules 457(c) and 457(h) of the Securities Act solely for the purpose of calculating the registration fee. The proposed maximum offering price per share of $4.29 was computed by averaging the high and low prices of a share of Registrant’s common stock as reported on The Nasdaq Stock Market LLC on March 13, 2025. |
(4) |
Represents additional shares to be registered and available for grant under the 2024 ESPP resulting from the annual 1% automatic increase in the number of authorized shares available for issuance under the 2024 ESPP. |
(5) |
Estimated in accordance with Rules 457(c) and 457(h) of the Securities Act solely for the purpose of calculating the registration fee. The proposed maximum offering price per share of $3.64 was computed by averaging the high and low prices of a share of Registrant’s common stock as reported on The Nasdaq Stock Market LLC on March 13, 2025, multiplied by 85%, which is the percentage of the trading price per share applicable to purchasers under the 2024 ESPP. |
(6) |
The Registrant does not have any fee offsets. |